COVID-19, The Continued BC-CfE Response

Dr. Julio Montaner
Executive Director & Physician-in-Chief
BC Centre for Excellence in HIV/AIDS
 
Dr. Peter Phillips
Clinical Professor
Division of Infectious Diseases, University of British Columbia
 
Dr. Zabrina Brumme and Dr. Chanson Brumme
Laboratory Director and Assistant Director, Research Laboratories
Laboratory Program
BC Centre for Excellence in HIV/AIDS
 
Dr. Junine Toy, Pharm D
Senior Manager, BC Centre for Excellence in HIV/AIDS Drug Treatment Program
Clinical Pharmacy Specialist, St. Paul’s Hospital
Share this video:
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below